# White Fish for Cardiovascular Risk Factors in Patients With Metabolic Syndrome: the WISH-CARE Study

Study · id `cardio:ct-nct01758601` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01758601](<https://clinicaltrials.gov/study/NCT01758601>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01758601

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 273 participants.

## Technical summary

Registry record NCT01758601. Randomized; no masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2011-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 273 participants (enrolled count; ClinicalTrials.gov record NCT01758601, source copy `cardio:ctgov-nct01758601-2017-03-08`, retrieved 2026-10-31)
- Start date: 2010-01 (registry gives no type) (ClinicalTrials.gov record NCT01758601, source copy `cardio:ctgov-nct01758601-2017-03-08`, retrieved 2026-10-31)
- Primary completion: 2011-12 (actual) (ClinicalTrials.gov record NCT01758601, source copy `cardio:ctgov-nct01758601-2017-03-08`, retrieved 2026-10-31)
- Completion: 2012-11 (actual) (ClinicalTrials.gov record NCT01758601, source copy `cardio:ctgov-nct01758601-2017-03-08`, retrieved 2026-10-31)
- Countries: Spain (ClinicalTrials.gov record NCT01758601, source copy `cardio:ctgov-nct01758601-2017-03-08`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01758601-2017-03-08`, retrieved 2026-10-31)

## The registry's words

- Brief title: White Fish for Cardiovascular Risk Factors in Patients With Metabolic Syndrome: the WISH-CARE Study
- Condition: Cardiovascular Risk Factors
- Condition: Metabolic Syndrome
- Intervention (Other): Dietary intervention with 7 servings oh white fish per week (each serve consisted of 100g of frozen Namibia hake, Pescanova S.A., Pontevedra, Spain)
- Intervention (Other): Previous alimentary habits, avoiding any significant nutritional imbalance, as well as any fish or seafood
- Lead sponsor: Hospital Universitario Ramon y Cajal
- Lead sponsor class: OTHER
- Collaborator: CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn).
- Collaborator class: UNKNOWN
- Collaborator: Pescanova S.A., Pontevedra, Spain.
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Metabolic syndrome (`cardio:metabolic-syndrome`)
- Registry lists this organization as the lead sponsor: Hospital Universitario Ramon y Cajal (`cardio:org-hospital-universitario-ramon-y-cajal`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: White fish reduces cardiovascular risk factors in patients with metabolic syndrome: the WISH-CARE study, a multicenter randomized clinical trial (`cardio:pubmed-24462043`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ee46fe56d7eb6c2bde6b22a6ae5d1beb308d04b00ae1c8314c52f575e1d88dc0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
